Teleflex TFX Vascular — Net revenues

Other product segments

Similar metrics at other companies

SYKVascular — Net Sales

$517M+27.3%

MDTCardiovascular — Net Sales

$3.8B+13.8%

BSXInterventional Cardiology & Vascular Therapies — Net Sales

$1.16B+10.5%

OGNOther Cardiovascular — Revenue

$28M-6.7%

BSXCardiovascular — Net Sales

$3.5B+13.5%

BSXCardiovascular — Net sales of reportable segments

$3.5B+10.9%

Questions, answered.

What is Teleflex's vascular — net revenues?

Teleflex (TFX) reported vascular — net revenues of $236.81M in Q1 2026.

How has Teleflex's vascular — net revenues changed year-over-year?

Teleflex's vascular — net revenues increased by 8.1% year-over-year, from $219.13M to $236.81M.

What is the long-term trend for Teleflex's vascular — net revenues?

Over 4 years (2021 to 2025), Teleflex's vascular — net revenues has grown at a 8.1% compound annual growth rate (CAGR), from $700.24M to $954.5M.

What does vascular — net revenues mean?

This metric represents the total net revenue generated from the sale of vascular access medical devices and related products. It reflects the financial performance of the business unit focused on products used for intravenous therapy, central venous access, and other bloodstream-related clinical procedures. Monitoring this revenue stream provides insight into the company's market position and demand trends within the critical care and vascular access medical device sector.